INTERNATIONAL SURVEY ON WILLINGNESS-TO-PAY (WTP) FOR ONE ADDITIONAL QALY GAINED: WHAT IS THE THRESHOLD OF COST EFFECTIVENESS?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shiroiwa, Takeru | - |
dc.contributor.author | Sung, Yoon-Kyoung | - |
dc.contributor.author | Fukuda, Takashi | - |
dc.contributor.author | Lang, Hui-Chu | - |
dc.contributor.author | Bae, Sang-Cheol | - |
dc.contributor.author | Tsutani, Kiichiro | - |
dc.date.accessioned | 2022-12-20T18:17:11Z | - |
dc.date.available | 2022-12-20T18:17:11Z | - |
dc.date.created | 2022-08-27 | - |
dc.date.issued | 2010-04 | - |
dc.identifier.issn | 1057-9230 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/175183 | - |
dc.description.abstract | Although the threshold of cost effectiveness of medical interventions is thought to be 20 pound 000-30 pound 000 in the UK, and $50 000-$100 000 in the US, it is well known that these values are unjustified, due to lack of explicit scientific evidence. We measured willingness-to-pay (WTP) for one additional quality-adjusted life-year gained to determine the threshold of the incremental cost-effectiveness ratio. Our study used the Internet to compare WTP for the additional year of survival in a perfect status of health in Japan, the Republic of Korea (ROK), Taiwan, Australia, the UK, and the US. The research utilized a double-bound dichotomous choice, and analysis by the nonparametric Turnbull method. WTP values were JPY 5 million (Japan), KWN 68 million (ROK). NT$ 2.1 million (Taiwan), 23000 (UK), AU$ 64 000 (Australia), and US$ 62 000 (US). The discount rates of outcome were estimated at 6.8% (Japan), 3.7% (ROK), 1.6% (Taiwan), 2.8% (UK), 1.9% (Australia), and 3.2% (US). Based on the current study, we suggest new classification of cost-effectiveness plane and methodology for decision making. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | JOHN WILEY & SONS LTD | - |
dc.title | INTERNATIONAL SURVEY ON WILLINGNESS-TO-PAY (WTP) FOR ONE ADDITIONAL QALY GAINED: WHAT IS THE THRESHOLD OF COST EFFECTIVENESS? | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sung, Yoon-Kyoung | - |
dc.contributor.affiliatedAuthor | Bae, Sang-Cheol | - |
dc.identifier.doi | 10.1002/hec.1481 | - |
dc.identifier.scopusid | 2-s2.0-77949723235 | - |
dc.identifier.wosid | 000276136200003 | - |
dc.identifier.bibliographicCitation | HEALTH ECONOMICS, v.19, no.4, pp.422 - 437 | - |
dc.relation.isPartOf | HEALTH ECONOMICS | - |
dc.citation.title | HEALTH ECONOMICS | - |
dc.citation.volume | 19 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 422 | - |
dc.citation.endPage | 437 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Business & Economics | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Economics | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Health Policy & Services | - |
dc.subject.keywordPlus | ADJUSTED LIFE YEAR | - |
dc.subject.keywordAuthor | cost-effectiveness analysis | - |
dc.subject.keywordAuthor | threshold | - |
dc.subject.keywordAuthor | QALY | - |
dc.subject.keywordAuthor | WTP | - |
dc.subject.keywordAuthor | double-bound dichotomous choice | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1002/hec.1481 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.